NO20044688L - Visse 1-(D-cyklopropylglysinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer for serin proteasefaktor Xa - Google Patents
Visse 1-(D-cyklopropylglysinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer for serin proteasefaktor XaInfo
- Publication number
- NO20044688L NO20044688L NO20044688A NO20044688A NO20044688L NO 20044688 L NO20044688 L NO 20044688L NO 20044688 A NO20044688 A NO 20044688A NO 20044688 A NO20044688 A NO 20044688A NO 20044688 L NO20044688 L NO 20044688L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitors
- cyclopropylglyinyl
- piperidin
- certain
- serine protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36852302P | 2002-04-01 | 2002-04-01 | |
PCT/US2003/007794 WO2003084929A1 (en) | 2002-04-01 | 2003-03-24 | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20044688L true NO20044688L (no) | 2004-10-29 |
Family
ID=28791889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044688A NO20044688L (no) | 2002-04-01 | 2004-10-29 | Visse 1-(D-cyklopropylglysinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer for serin proteasefaktor Xa |
Country Status (25)
Country | Link |
---|---|
US (1) | US7166606B2 (ja) |
EP (1) | EP1492767B1 (ja) |
JP (1) | JP2005531529A (ja) |
KR (1) | KR20040094892A (ja) |
CN (1) | CN1288135C (ja) |
AT (1) | ATE303990T1 (ja) |
AU (1) | AU2003218147A1 (ja) |
BR (1) | BR0308870A (ja) |
CA (1) | CA2478340A1 (ja) |
CR (1) | CR7497A (ja) |
DE (1) | DE60301569T2 (ja) |
DK (1) | DK1492767T3 (ja) |
EA (1) | EA007300B1 (ja) |
EC (1) | ECSP045329A (ja) |
ES (1) | ES2248737T3 (ja) |
HK (1) | HK1070363A1 (ja) |
HR (1) | HRP20040900B1 (ja) |
IL (1) | IL164018A0 (ja) |
MX (1) | MXPA04009640A (ja) |
NO (1) | NO20044688L (ja) |
NZ (1) | NZ535402A (ja) |
PL (1) | PL373066A1 (ja) |
UA (1) | UA76849C2 (ja) |
WO (1) | WO2003084929A1 (ja) |
ZA (1) | ZA200407418B (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6834308B1 (en) | 2000-02-17 | 2004-12-21 | Audible Magic Corporation | Method and apparatus for identifying media content presented on a media playing device |
EP1490767B1 (en) | 2001-04-05 | 2014-06-11 | Audible Magic Corporation | Copyright detection and protection system and method |
US8972481B2 (en) | 2001-07-20 | 2015-03-03 | Audible Magic, Inc. | Playlist generation method and apparatus |
DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
EP3541381B1 (en) | 2016-11-18 | 2022-12-28 | Merck Sharp & Dohme LLC | Inhibitors of factor xiia |
EP4070658A1 (de) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Verwendung von blutgerinnungshemmenden verbindungen als rodentizide |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1009758B1 (en) | 1997-08-29 | 2005-06-01 | Tularik Limited | Meta-benzamidine derivatives as serine protease inhibitors |
AU5413600A (en) | 1999-06-14 | 2001-01-02 | Eli Lilly And Company | Compounds |
CA2375920A1 (en) | 1999-06-14 | 2000-12-21 | Eli Lilly And Company | Compounds |
GB0030306D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
GB0030303D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
GB0030305D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
TWI257389B (en) | 2001-06-12 | 2006-07-01 | Lilly Co Eli | Pharmaceutical compound |
ES2298386T3 (es) * | 2001-07-26 | 2008-05-16 | Eli Lilly And Company | 1-glicinil-4-(1-metilpiperidin-4-il)piperazinas y -piperidinas como antagonistas del factor xa. |
-
2003
- 2003-03-24 CA CA002478340A patent/CA2478340A1/en not_active Abandoned
- 2003-03-24 KR KR10-2004-7015486A patent/KR20040094892A/ko not_active Application Discontinuation
- 2003-03-24 IL IL16401803A patent/IL164018A0/xx unknown
- 2003-03-24 DK DK03714138T patent/DK1492767T3/da active
- 2003-03-24 AU AU2003218147A patent/AU2003218147A1/en not_active Abandoned
- 2003-03-24 JP JP2003582128A patent/JP2005531529A/ja active Pending
- 2003-03-24 US US10/486,138 patent/US7166606B2/en not_active Expired - Fee Related
- 2003-03-24 MX MXPA04009640A patent/MXPA04009640A/es active IP Right Grant
- 2003-03-24 UA UA20041008649A patent/UA76849C2/uk unknown
- 2003-03-24 NZ NZ535402A patent/NZ535402A/en unknown
- 2003-03-24 BR BR0308870-7A patent/BR0308870A/pt not_active IP Right Cessation
- 2003-03-24 EA EA200401290A patent/EA007300B1/ru not_active IP Right Cessation
- 2003-03-24 CN CNB038074141A patent/CN1288135C/zh not_active Expired - Fee Related
- 2003-03-24 AT AT03714138T patent/ATE303990T1/de not_active IP Right Cessation
- 2003-03-24 DE DE60301569T patent/DE60301569T2/de not_active Expired - Fee Related
- 2003-03-24 PL PL03373066A patent/PL373066A1/xx unknown
- 2003-03-24 ES ES03714138T patent/ES2248737T3/es not_active Expired - Lifetime
- 2003-03-24 EP EP03714138A patent/EP1492767B1/en not_active Expired - Lifetime
- 2003-03-24 WO PCT/US2003/007794 patent/WO2003084929A1/en active IP Right Grant
-
2004
- 2004-09-15 ZA ZA200407418A patent/ZA200407418B/en unknown
- 2004-09-24 CR CR7497A patent/CR7497A/es unknown
- 2004-09-29 EC EC2004005329A patent/ECSP045329A/es unknown
- 2004-09-30 HR HR20040900A patent/HRP20040900B1/xx not_active IP Right Cessation
- 2004-10-29 NO NO20044688A patent/NO20044688L/no not_active Application Discontinuation
-
2005
- 2005-04-11 HK HK05103052A patent/HK1070363A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ535402A (en) | 2006-02-24 |
ES2248737T3 (es) | 2006-03-16 |
ECSP045329A (es) | 2004-11-26 |
EA007300B1 (ru) | 2006-08-25 |
WO2003084929A8 (en) | 2004-05-21 |
AU2003218147A1 (en) | 2003-10-20 |
ATE303990T1 (de) | 2005-09-15 |
WO2003084929A1 (en) | 2003-10-16 |
BR0308870A (pt) | 2005-01-04 |
UA76849C2 (uk) | 2006-09-15 |
CN1642914A (zh) | 2005-07-20 |
IL164018A0 (en) | 2005-12-18 |
US20050096328A1 (en) | 2005-05-05 |
ZA200407418B (en) | 2005-09-15 |
DE60301569D1 (de) | 2005-10-13 |
EA200401290A1 (ru) | 2005-02-24 |
KR20040094892A (ko) | 2004-11-10 |
MXPA04009640A (es) | 2005-01-11 |
JP2005531529A (ja) | 2005-10-20 |
HRP20040900A2 (en) | 2004-12-31 |
EP1492767A1 (en) | 2005-01-05 |
DE60301569T2 (de) | 2006-06-14 |
PL373066A1 (en) | 2005-08-08 |
CA2478340A1 (en) | 2003-10-16 |
CN1288135C (zh) | 2006-12-06 |
EP1492767B1 (en) | 2005-09-07 |
DK1492767T3 (da) | 2005-11-28 |
HRP20040900B1 (en) | 2006-02-28 |
US7166606B2 (en) | 2007-01-23 |
HK1070363A1 (en) | 2005-06-17 |
CR7497A (es) | 2005-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1091121A1 (en) | Substituted 2-aminotetralins for the treatment of depressions | |
IS2416B (is) | Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar | |
NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
NO20070201L (no) | Seksleddede heterocykler anvendelige som serinproteaseinhibitorer | |
DK1836201T4 (da) | Pyrrolidininhibitorer af IAP. | |
DE602006011752D1 (de) | Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate | |
WO2006047528A3 (en) | Pyrazolobenzamides and derivatives as factor xa inhibitors | |
IS6902A (is) | N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl | |
DK1585739T3 (da) | Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer | |
RS20050046A (en) | 3-z-/1-(4-(n-((4-methyl-piperazin-1-yl)- methylcarbonyl)-n- methyl-amino)- anilino)-1-phenyl-methylene/-6- methoxycarbonyl -2-indolinone- monoethanesulphonate and the use thereof as a pharmaceutical composition | |
NO20050199L (no) | Azadisyklo-oktan og nonanderivater med DDP-IV-inhiberende aktivitet | |
MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
NO20082629L (no) | Macrocyklisk factor VIIa-inhibitorer anvendbare som antikoagulanter | |
NO20063944L (no) | Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister | |
GB0426313D0 (en) | Therapeutic agents | |
WO2004031145A3 (en) | Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors | |
HK1070363A1 (en) | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa | |
AR039937A1 (es) | Derivados de azetidina como inhibidores de tripsina proteasas | |
WO2004108892A3 (en) | 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS | |
MY137876A (en) | Pharmaceutical compound | |
DK1637141T3 (da) | Stabiliseret proteasesammensætning omfattende en serinprotease, morpholinderivater og reversible inhibitorer af serinproteasen | |
EA200601086A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
EA200700186A1 (ru) | Фармацевтическое соединение | |
DE60224805D1 (de) | 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine un | |
SI1492767T1 (sl) | Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |